Skip to Main Content

Paper Details

Genomic aberrations in cell cycle genes predict progression of KIT-mutant gastrointestinal stromal tumors (GISTs).
Clin Sarcoma Res
23
2019
CDKN2A, CDKN2A/B, GIST, GISTs, KIT, KIT mutations, KIT-mutant, KIT-mutant GIST, KIT-mutant gastrointestinal stromal tumors, KIT-mutant micro-GISTs, RB1, TP53, cancer, cell cycle genes, cell cycle-associated genes, cell cycle-related genes, gastrointestinal stromal tumors, malignant, malignant GIST, malignant disease, oncogenic KIT, patients, receptor tyrosine kinase, spliceosome genes, tumor, tumors, tyrosine
Author NameAffiliation
Christopher L CorlessPortland VA Health Care System and OHSU Knight Cancer Institute, 3710 SW U.S. Veterans Hospital Road
Brian P RubinCleveland Clinic and Lerner Research Institute
Brian P RubinCleveland Clinic and Lerner Research Institute
  • 1 - 3

Datasets

Release 1.2